Trials / Completed
CompletedNCT01530685
Gycabiane and Glycemic Control of Prediabetic Subjects
Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- PiLeJe · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.
Detailed description
Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear. The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glycabiane | 2 gelule per day for 4 months |
| DIETARY_SUPPLEMENT | placebo | 2 gelules per day for 4 months |
Timeline
- Start date
- 2011-10-27
- Primary completion
- 2012-09-25
- Completion
- 2012-09-25
- First posted
- 2012-02-10
- Last updated
- 2021-04-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01530685. Inclusion in this directory is not an endorsement.